Schistosomiasis is a major global health problem caused by blood-dwelling parasitic worms and is currently treated by the mass administration of the drug praziquantel. Appropriate drug treatment strategies are informed by diagnostics that establish the prevalence and intensity of infection, which, in regions of low transmission should be highly sensitive. To identify sensitive new serological markers of Schistosoma mansoni infections, we have compiled a recombinant protein library of 115 parasite cell surface and secreted proteins expressed in mammalian cells. The vast majority of them were shown to be immunoreactive and to contain heat-labile conformational epitopes when tested against pooled human sera from endemic regions. After probing the library against a time series of sera samples from experimental infections in mice, we identified several markers of infection, the majority of which belong to the saposin-domain-containing and cathepsin families of proteins. These new markers will be a valuable tool to detect ongoing and previous S. mansoni infections, including in regions of low transmission. We envisage that this new recombinant protein resource will be used in a wide range of cellular and molecular assays to further our understanding of Schistosoma biology.
Introduction
Schistosomiasis is a parasitic disease affecting over 200 million people in 52 countries and is considered one of the world's major health problems causing 200,000 deaths per year. In 2015, the impact of the disease was estimated at 3.5 million disability-adjusted life years (DALYS), putting a huge socio-economic burden on many low and middle-income countries [1] . In humans, schistosomiasis is caused by five species of platyhelminth parasite belonging to the genus Schistosoma. Their geographical distribution is restricted by the presence of species-specific freshwater snails that act as intermediate hosts, with S. mansoni having the most widespread distribution, encompassing both Africa and South America [2] . Infected snails shed cercariae, a freeswimming form of the parasite, which penetrates human skin to initiate infection. Maturation of the parasite within its human host takes several weeks: cercariae first remodel their surface to form schistosomula [3, 4] , which migrate through the dermis for several days before entering the host bloodstream. Eventually, young adult male and female S. mansoni worms pair up in the liver before moving to the mesenteric blood vessels, where each pair can release over 300 eggs per day from around five weeks post-infection [5] . The symptoms of the disease are caused by progressive accumulation of eggs within host tissues which elicit host-derived inflammatory responses that can eventually lead to liver fibrosis, portal hypertension and, if left untreated, death [6] . In the absence of a licenced vaccine, preventative treatment relies on the use of a single drug, praziquantel.
The exact prevalence of schistosomiasis worldwide may be underestimated because of the limitations of routine methods of detection [7] . Diagnosis of S. mansoni infections and subsequent decisions on mass drug administration mainly rely on observing parasite eggs in the stools of patients: the Kato-Katz test. Although this method can detect current infections, it is not sufficiently sensitive to diagnose low levels of infection present in areas of low-endemicity, or in recentlytreated populations [8, 9] . In these instances, the direct detection of parasite antigens such as the circulating anodic antigen (CAA) in patients' sera is a more sensitive method [10] . In areas where elimination has been achieved, the detection of anti-parasite antibodies in patients' sera is a good approach to monitor historical exposure to the parasite, thus avoiding any risk of resurgence. Host antibody responses to S. mansoni parasites is often measured against whole parasite extracts such as soluble egg antigens (SEA) or soluble worm antigen preparation (SWAP), which are not molecularly defined and can lead to cross-reactivity with other helminths species. While a diagnostic test based on a recombinant protein could mitigate these problems, only very few have been used to test patient antibody responses to Schistosoma infections [11] . The development of new, more sensitive diagnostic tools would therefore help to improve the detection and early treatment of schistosomiasis.
Extracellular antigens released by or displayed at the surface of the parasite at the initial stage of infection can be valuable early immunodiagnostic markers as they are directly exposed to the host humoral system [3] . The identification of such antigens has been aided by the sequencing and annotation of the S. mansoni genome [12] and several proteomics [13] [14] [15] [16] [17] [18] [19] [20] [21] , transcriptional [22] [23] [24] [25] [26] [27] and in silico analyses [28] , which have identified genes expressed by the schistosomula and adult worm. Despite their value, extracellular proteins pose challenges for recombinant expression because they contain structurally important posttranslational modifications such as glycosylation and especially disulphide bonds, which are often required to produce informative antibody epitopes.
To address this, we have previously developed protein expression approaches using a mammalian system that can be used to compile large panels of parasite secreted recombinant ectodomains that retain their binding activity and immunogenicity [29, 30] , enabling the identification of host-parasite receptor-ligand interactions and humoral markers of protection against malaria [31] .
To identify new markers for S. mansoni infections, we created a panel of 115 recombinant proteins representing secreted and membrane-tethered S. mansoni proteins that were mostly enriched for expression at the schistosomula stage. Using mouse sera from experimentally-controlled S. mansoni infections, we were able to identify several early serological markers of infection mostly belonging to the saposin-containing and cathepsin families of protein.
Material and methods

Identification of S. mansoni cell-surface and secreted proteins
Genes encoding cell surface and secreted proteins from S. mansoni were identified using published proteomic and transcriptional data [13] [14] [15] [16] [19] [20] [21] [22] [23] . To enrich for genes transcribed at the schistosomula stage, we identified 1,302 transcripts upregulated at 48 compared to 3 hours posttransformation [32] using EdgeR [33] as well as the 1,000 most abundant transcripts at 48 hours as assessed by reads per kilobase mapped, resulting in 1,977 unique genes. Genes encoding 274 secreted and cell surface proteins were identified from this list using signal peptide and transmembrane domain prediction software [34, 35] . Proteins spanning the membrane multiple times and therefore difficult to express as a contiguous ectodomain, and those with sequence homologies to mitochondrial or endoplasmic reticulum proteins were subsequently excluded, leaving a shortlist of 180 proteins. Gene structures were manually refined by mapping transcriptome data to the genome sequence, and those genes which spanned gaps in the genome sequence, or with ambiguity in the gene structure (e.g. due to genome misassemblies) were removed, resulting in a final list of 115 candidates. Because most proteins were previously uncharacterised and therefore known only by their database accession numbers, all proteins described in this study were given numbers, which we use throughout the text for convenience (Table 1) .
Recombinant protein expression using a mammalian expression system
For membrane anchored proteins, the entire ectodomain was selected and the signal peptide removed using predictions from SignalP v3.0 [34] . Corresponding cDNAs were made by gene synthesis and codon-optimised for expression in human cells (Invitrogen, GeneArt). The ectodomains were flanked by unique NotI and AscI restriction enzyme sites and subcloned into an expression plasmid containing a high-scoring signal peptide [29] , and a C-terminal tag containing rat Cd4d3+4 domain, a BirA monobiotinylation sequence, and 6-His tag (Addgene plasmid# 50803) [36] .
All expression constructs have been deposited with Addgene (Addgene plasmids #120590 to 120704). Plasmids were transiently transfected in HEK293-E or HEK293-6E cells [37] and supernatants collected as previously described [38] , and detected by Western blotting with 0.02 µg/mL streptavidin-HRP (Jackson Immunoresearch) as described [29] . Where proteins showed signs of proteolytic cleavages, transfections were repeated in the presence of a protease inhibitor cocktail (Sigma).
Human sera from endemic regions infections
A pool of sera from ten Ugandan adults living in a high-transmission area showing high soluble worm antigen IgG1 responses and treated with praziquantel [39, 40] or non-exposed European control sera were used to initially characterise the proteins. All patient samples were collected in accordance with the Uganda National Council for Science and Technology (UNCST) and the Cambridge Local Research Ethics Committee.
Sera from experimental mouse infections
The life cycle of the NMRI (Puerto Rican) strain of Schistosoma mansoni was maintained by routine 
Enzyme-linked immunosorbent assays (ELISAs)
Protein expression was quantified by ELISA as described [29] . Briefly, biotinylated proteins were diluted in HBST/2%BSA and captured on streptavidin-coated microtitre plates and detected by mouse anti-rat Cd4 OX68 antibody (AbD Serotec), followed by an alkaline-phosphatase-conjugated anti-mouse secondary antibody (Sigma). Based on the ELISA readings, proteins were classified into high (typically >5 µg/mL transfection supernatant), medium (between 1 and 5 µg/mL transfection supernatant) and low (<1 µg/mL transfection supernatant) levels of expression. To determine the presence of heat labile epitopes, biotinylated proteins were captured on streptavidin-coated plates either untreated or following heat-treatment for 10 minutes at 80°C before being incubated with sera at 1:1,000 dilution in HBST/2%BSA. Sera from experimentally-infected mice were diluted 1:1000 in HBST/2%BSA and binding was detected with a horseradish peroxidase (HRP)-conjugated antimouse secondary antibody recognising IgA, IgM and IgG. Analysis was performed for each individual by reference-subtracting the OD value of the pre-infection samples from the OD readings at all subsequent time points. OD values for each protein were compared to that of a negative control and seropositivity was defined as OD protein > OD control + 3SD control .
Results
Selection and expression of a panel of 115 secreted and cell-surface proteins from Schistosoma mansoni
To compile a library of recombinant S. mansoni proteins that could be used for immunodiagnostics screening, we first made use of published proteomics data from the cercarial, schistosomula or adult stages. We identified those with features of cell surface and secreted proteins and selected a panel of 36 proteins (Table 1) . Because of the difficulty in solubilising membrane-embedded proteins and the fact that glycosylated peptides are often uninformative in mass-spectrometry-based approaches, we sought to further enrich our library using transcriptomics data. To identify genes transcribed early after infection, we selected 1,302 transcripts enriched at 48 versus 3 hours post-infection, and the 1,000 most abundant transcripts in the 48-hour schistosomula. Proteins likely to be secreted or membrane-anchored were identified from these sets based on the presence of a N-terminal signal peptide or membrane-anchoring sequences, resulting in a list of 274 genes. Since the correct folding of recombinant proteins critically depends on correct gene structure, manual curation was performed on all candidates to check for completeness of their open reading frames. After further removal of mitochondrial, endoplasmic reticulum and multiple-pass membrane proteins, 79 secreted or membrane-anchored candidates with correct gene structures were added to the shortlist, resulting in a final set of 115 genes (Table 1 ). Approximately one third of the selected genes encoded single-pass transmembrane or GPI-anchored proteins, while the remaining two thirds were secreted proteins and enzymes. Based on sequence similarities with other proteins, these secreted proteins and enzymes were further divided into five broad categories: secreted adhesion and metabolite-binding proteins, secreted proteases, other secreted enzymes, secreted venom allergenlike (VAL) and micro-exon genes (MEG), and finally putative secreted proteins with no known homology. Proteins were expressed in HEK293 cells, quantified by ELISA, and their integrity determined by Western blotting (Figure 1 ). The majority of the proteins produced could be detected at their expected full-length size including the very large proteins Sm200 (257kDa, Protein 4) and α2-macroglobulin (409kDa, Protein 72), and only twelve proteins (10%) could not be detected by ELISA or Western blot (Table 1, Figure 1 ). Using a mammalian expression system, we were therefore able to successfully produce over a hundred recombinant S. mansoni surface and secreted proteins, which will be a valuable resource for functional and immunological studies.
S. mansoni recombinant proteins expressed in mammalian cells contain heat-labile conformational epitopes
Many antibodies that are elicited in the context of a natural infection recognise conformational epitopes displayed on the native protein. Since most of the proteins selected in the library have no known function or binding partners, we determined which fraction of the proteins contained conformational epitopes by comparing the immunoreactivity of pooled sera from ten adult Ugandan patients living in a high-transmission area to untreated and heat-treated proteins ( Figure 2 ). All proteins except numbers 18 and 57 were seropositive, and sixty-six of the expressed proteins (64%) were highly immunoreactive with an OD reading > 0.3 ( Figure 2 ). The majority of proteins showed moderate to strong loss of immunoreactivity after heat-treatment with only twelve proteins showing little or no loss of reactivity, suggesting that these latter proteins were either natively unstructured, misfolded, or contained heat-stable domains (Figure 2) . In summary, the majority of the recombinant proteins produced were reactive against immunoglobulins from individuals living in high-endemicity areas, who have experienced infections with S. mansoni. The decrease in reactivity observed after heat-treatment suggest that most of these recombinant proteins contain conformational epitopes that are also present in native S. mansoni proteins and are recognised by host antibodies in the context of a natural infection. showed reactivity across all sera tested (Proteins 10, 41, 62, 63, 64, 67, 68, and 106) and all but one mouse showed strong reactivity to protein 71. Overall, reactivity with the pool of sera from mice infected intraperitoneally was stronger than individual mice infected percutaneously, which might be a reflection of the higher number of cercariae used. Proteins 44, 62, 63, 67 and 68, which all belong to either the saposin-containing or cathepsin families, were the most immunoreactive, along with protein 106. In addition, reactivity to three Ly6 family members Ly6F, Ly6B and Ly6D (proteins 3, 10, and 41, respectively) was also detected. Overall, however, members of the saposin-containing and cathepsin families appeared to be the most immunoreactive proteins in the murine model at a relatively early stage of infection.
The humoral response elicited by mixed infections in mice identifies cathepsins and saposin-domaincontaining proteins as early markers of infection
Discussion
Despite its widespread distribution and high morbidity rate, schistosomiasis remains a neglected tropical disease whose true incidence and health impact likely remains underestimated. Here, we have described a recombinant protein library containing 115 secreted and cell-surface proteins from different developmental stages of Schistosoma mansoni. We used this new valuable resource to determine the kinetics of the mouse humoral response to S. mansoni infections. While other large arrays of parasite proteins have been used for diagnostic and immuno-epidemiological purposes, they have mostly relied on cell-free or bacterial expression systems [41] [42] [43] . Mammalian expression systems are more suitable for the addition of structurally important posttranslational modifications found on extracellular proteins and thereby preserve conformational epitopes that can be recognised by antibodies. Using this approach, we successfully expressed over one hundred of these proteins, the majority of which were observed at their expected size. Although the twelve proteins that could not be expressed were equally distributed amongst the different protein families represented in the library, three of them corresponded to elastases. Using sera from patients living in a high-transmission region of Uganda, we observed that 64% of the expressed proteins were considered to be strongly immunoreactive (OD>0.3) with the majority (82%) showing sensitivity to heat-treatment, an indicator of tertiary folding. Although the lower immunoreactivity for 37 proteins may suggest incorrect folding, they could also be weakly immunogenic in humans, or not directly exposed to the host immune system. Although a large fraction of the natural host immune response has been reported to be directed against parasite glycans present at different stages of development [44] [45] [46] , the conformation-sensitive immunoreactivity that we observed in our assay is almost certainly directed against the protein backbones since the immunoreactivity against glycans would not be affected by heat-treatment and the glycan groups added on the recombinant proteins in HEK293 cells may differ substantially from the ones present on endogenous proteins. Of the sixteen most immunoreactive proteins observed, eleven had already been identified in the surface and secreted proteome of S. mansoni; by contrast, only six out of the 37 proteins with low serum reactivity (16%) have already been described in proteomics studies. The use of a single mammalian expression system for the production of large panels of recombinant proteins is particularly attractive for the systematic comparison of antigens in diagnostic, immuno-epidemiological or vaccination studies and we have used this approach previously for the identification of potentially protective antibodies against malaria [29, 31, 36, 47] .
Mass administration of praziquantel to schoolchildren has been the mainstay of control programmes against schistosomiasis and this has proved relatively successful in reducing parasite burdens and contributing to elimination from some areas. Continued surveillance and early detection of new cases remains critical to avoid any risk of resurgence; however, the commonly used Kato-Katz method is not sensitive enough to detect low levels of infection, resulting in the underestimation of the number of cases [9] . Detection of parasite-derived glycans such as the circulating anodic antigen (CAA) in the urine or serum of patients by lateral-flow test is currently considered the most sensitive point-of-care assay for the detection of current Schistosoma infections as reactivity disappears rapidly following praziquantel treatment. In areas where schistosomiasis has been eliminated or is close to elimination, alternative methods of surveillance might be needed. By persisting several months or even years after infection [48] , antibody responses provide a useful historical measure of parasite exposure and are better suited for monitoring populations at risk of resurgence. Currently, most host antibody responses are measured against crude parasite preparations such SEA or SWAP, which suffer from considerable cross-reactivity with other helminths antigens. The use of speciesspecific recombinant proteins as diagnostics could therefore be more reliable.
A striking feature of this study is the relatively small number of antigens eliciting a patent immune response in the few weeks following a primary infection, which could reflect the ability of the parasite to evade the host immune response. Strikingly, the antibody responses observed at 6 weeks were dominated by saposin-containing and cathepsin proteins: out of the ten proteins that showed reactivity in all animals at 6 weeks post-infection, four were saposin-domain-containing proteins and two were cathepsins. Proteins 66 and 67 are two isoforms of the Cathepsin B1 protease that has been suggested to have inbuilt adjuvanticity [49] . Interestingly, SjSAPLP1 and SjSAPLP4, the Schistosoma japonicum orthologs of proteins 44 and 63 respectively, have been proposed as markers of infections in mice and humans [50, 51] , and it is therefore likely that S. mansoni orthologs of saposin-domain-containing proteins will be early markers of infection in human sera too. Both saposins and cathepsins are produced in the parasite's gut and have been involved in the digestion of lipids and proteins [52, 53] but their transcriptional up-regulation at the cercarial and day3 schistosomula stages suggest they might also play a role in the gut of the parasite larvae [26] . Their exposure to the humoral system of infected individuals suggests they are regurgitated by the worm during the feeding process. While several saposin-domain-containing proteins present in the library were immunoreactive, their sequence identity ranged between 9 and 28%, making cross-reactivity unlikely.
Another group of immunoreactive proteins consistently observed across samples were members of the uPAR/Ly6 domain-containing family, whose expression has been reported at the schistosomule and adult stages [54] [55] [56] . In our study, reactivity to three members (Proteins 3, 10 and 41) corresponding to Ly6F, B and D, respectively was observed in mouse serum samples. These proteins have previously been shown to elicit strong antibody responses in rat, mouse and human sera [56] .
Members of this family share some homology with the complement-inactivating Cd59 protein although they do not seem to have preserved this function [54] .
Quantitation of gene expression suggests that these genes are, however, already actively transcribed at the schistosomula stage [15, 54, 55] , several weeks before reactivity from host antibodies can be detected. The ability of schistosomes to manipulate and evade the host immune system has been described although the specific proteins and mechanisms orchestrating this escape are not yet clearly defined [57] [58] [59] [60] .
By producing our recombinant proteins in a mammalian expression system, we have paid particular attention to their correct folding, and thus this new resource could be used in a wide range of cellular and molecular assays such as vaccine screening, cellular assays looking at immunomodulatory functions, immunoepidemiological studies, or the identification of host binding partners by receptor-ligand screening. We envisage these proteins will be useful to the wider scientific community to further understand Schistosoma biology. Recombinant proteins were probed with pooled sera from individuals living in schistosomiasis-endemic areas ("immune", red checkered bars) or individuals from the UK who have never been infected ("naïve", green dotted bars). To test for the presence of heat-labile epitopes, recombinant proteins were also heat-treated to 80°C for 10 minutes before being exposed to immune sera ("immune heat treated", orange hatched bars). Most proteins were immunoreactive when exposed to sera from endemic areas and contained heat-labile epitopes as shown by a decrease of reactivity following heattreatment. All measurements were performed in triplicate; error bars = SD. 
